Total Payments
$598,064
2024 Payments
$47,944
Companies
47
Transactions
742
Medicare Patients
1,699
Medicare Billing
$245,549
Payment Breakdown by Category
Consulting$363,255 (60.7%)
Travel$132,518 (22.2%)
Other$87,804 (14.7%)
Food & Beverage$13,617 (2.3%)
Education$870.46 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $363,255 | 95 | 60.7% |
| Travel and Lodging | $132,518 | 178 | 22.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $60,429 | 13 | 10.1% |
| Honoraria | $14,950 | 9 | 2.5% |
| Food and Beverage | $13,617 | 437 | 2.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $12,425 | 6 | 2.1% |
| Education | $870.46 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $256,701 | 196 | $0 (2024) |
| Merck Sharp & Dohme LLC | $121,201 | 98 | $0 (2023) |
| ABBVIE INC. | $104,137 | 216 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $29,809 | 25 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $27,319 | 90 | $0 (2024) |
| Novo Nordisk Inc | $26,044 | 15 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $9,726 | 4 | $0 (2019) |
| Abbott Laboratories | $6,819 | 11 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $4,120 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,900 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47,944 | 66 | Novo Nordisk Inc ($26,011) |
| 2023 | $78,637 | 96 | Gilead Sciences, Inc. ($63,966) |
| 2022 | $17,992 | 68 | ABBVIE INC. ($7,969) |
| 2021 | $57,105 | 52 | Gilead Sciences, Inc. ($32,466) |
| 2020 | $39,285 | 46 | Gilead Sciences, Inc. ($18,513) |
| 2019 | $67,151 | 109 | AbbVie, Inc. ($30,549) |
| 2018 | $114,242 | 128 | Gilead Sciences, Inc. ($58,896) |
| 2017 | $175,708 | 177 | Merck Sharp & Dohme Corporation ($89,927) |
All Payment Transactions
742 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,125.00 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $7.30 | General |
| Category: LIVER DISEASE | ||||||
| 11/25/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $6.14 | General |
| Category: LIVER DISEASE | ||||||
| 11/17/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $135.52 | General |
| Category: LIVER DISEASE | ||||||
| 11/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $35.76 | General |
| Category: VIROLOGY | ||||||
| 11/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.39 | General |
| 10/23/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $2,120.00 | General |
| Category: CRITICAL CARE | ||||||
| 10/07/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.61 | General |
| 09/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.15 | General |
| 09/20/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $11,043.75 | General |
| 09/20/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $876.82 | General |
| 09/20/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $232.82 | General |
| 09/20/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $223.54 | General |
| 09/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $199.95 | General |
| 09/20/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $62.98 | General |
| 09/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.74 | General |
| 09/11/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/03/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: GI | ||||||
| 08/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $98.26 | General |
| 08/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.42 | General |
| 08/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: Gastroenterology | ||||||
| 08/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.62 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 418 | 517 | $153,539 | $57,164 |
| 2022 | 7 | 451 | 597 | $171,643 | $65,409 |
| 2021 | 7 | 463 | 636 | $185,467 | $70,051 |
| 2020 | 6 | 367 | 529 | $157,127 | $52,925 |
Total Patients
1,699
Total Services
2,279
Medicare Billing
$245,549
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 190 | $41,990 | $17,437 | 41.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 86 | 86 | $31,562 | $10,828 | 34.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 46 | $14,720 | $6,514 | 44.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 61 | $15,433 | $6,207 | 40.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 33 | $16,368 | $4,892 | 29.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $12,090 | $4,586 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 33 | 36 | $7,956 | $2,596 | 32.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 16 | 19 | $6,080 | $2,228 | 36.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 20 | 20 | $7,340 | $1,876 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 200 | $44,200 | $19,730 | 44.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 50 | 111 | $28,083 | $9,564 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 71 | 71 | $26,057 | $8,989 | 34.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 37 | 40 | $19,840 | $6,791 | 34.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 34 | $10,880 | $4,985 | 45.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $11,625 | $4,458 | 38.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 27 | 35 | $11,200 | $4,158 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 40 | 50 | $11,050 | $3,962 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 14 | 14 | $5,138 | $1,502 | 29.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 13 | 17 | $3,570 | $1,270 | 35.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 129 | 173 | $38,233 | $16,548 | 43.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 55 | 135 | $34,155 | $12,046 | 35.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 61 | 61 | $22,387 | $7,964 | 35.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 36 | 38 | $18,848 | $6,583 | 34.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 34 | 45 | $14,400 | $6,532 | 45.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 32 | 32 | $14,880 | $5,737 | 38.6% |
About Dr. Nancy Reau, MD
Dr. Nancy Reau, MD is a Gastroenterology healthcare provider based in Burr Ridge, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164585683.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nancy Reau, MD has received a total of $598,064 in payments from pharmaceutical and medical device companies, with $47,944 received in 2024. These payments were reported across 742 transactions from 47 companies. The most common payment nature is "Consulting Fee" ($363,255).
As a Medicare-enrolled provider, Reau has provided services to 1,699 Medicare beneficiaries, totaling 2,279 services with total Medicare billing of $245,549. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Burr Ridge, IL
- Active Since 12/18/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1164585683
Products in Payments
- Mavyret (Drug) $29,727
- Epclusa (Drug) $28,343
- XIFAXAN (Drug) $27,121
- ZEPATIER (Drug) $23,766
- MAVYRET (Drug) $22,130
- OCALIVA (Drug) $13,931
- Viekira (Drug) $12,565
- Viekira Pak (Drug) $11,432
- OPDIVO (Biological) $9,726
- Vemlidy (Drug) $8,930
- OCA (Drug) $3,640
- ARCHITECT (Device) $3,041
- TERLIVAZ (Drug) $2,120
- Architect Anti-HCV (Device) $2,018
- Architect system (Device) $1,711
- FibroScan (Device) $1,515
- TE7 MAX (Device) $1,500
- Wako HCC Biomarker(s) DCP and AFP-L3 (Device) $850.00
- Mulpleta (Drug) $799.37
- STELARA (Biological) $302.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Burr Ridge
Irving Waxman, Md, MD
Gastroenterology — Payments: $163,296
Gastroenterology $163,296
Dr. Sujit Janardhan, M.d., Ph. D, M.D., PH. D
Gastroenterology — Payments: $65,373
Gastroenterology $65,373
Carol Semrad, Md, MD
Gastroenterology — Payments: $4,066
Gastroenterology $4,066
Eugene Chang, Md, MD
Gastroenterology — Payments: $123.80
Gastroenterology $123.80